- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens invests in MI firm
VisEn Medical, a developer of agents and systems in the field of molecular imaging, has a new partner. Siemens has taken an equity stake in the company in an effort to promote the development of MI technology and expand the markets for in vivo imaging of
VisEn Medical, a developer of agents and systems in the field of molecular imaging, has a new partner. Siemens has taken an equity stake in the company in an effort to promote the development of MI technology and expand the markets for in vivo imaging of molecular events. VisEn, which was founded in June 2000 on technologies developed at Massachusetts General Hospital and Harvard Medical School, is focusing on technology for imaging cancer, atherosclerosis, and rheumatoid arthritis.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
